Vı́tězslav Kolek
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 22
- Lung Cancer Treatments and Mutations 18
- Lung Cancer Diagnosis and Treatment 11
- Chronic Obstructive Pulmonary Disease (COPD) Research 6
- Oncology top 10%
- Lung Cancer Research Studies 16
- Physiology top 10%
- Sarcoidosis and Beryllium Toxicity Research 21
- Obstructive Sleep Apnea Research 5
-
- Pneumonia and Respiratory Infections 6
- Co-authors
- Martin PetřekZdeňka NavrátilováRoland M. du BoisJir̆ı́ DrábekKenneth I. WelshEva KriegováJozef ŠkardaFrantišek Mrázek
- Journals
- Journal of Clinical Oncology (1 paper)PLoS ONE (4 papers)American Journal of Respiratory and Critical Care Medicine (4 papers)
- Partner nations
- CzechiaUnited KingdomIsrael
In The Last Decade
Vı́tězslav Kolek
79 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Pulmonary and Respiratory Medicine 746
- Oncology 413
- Physiology 356
- Cancer Research 158
- Immunology 130
Countries citing papers authored by Vı́tězslav Kolek
This map shows the geographic impact of Vı́tězslav Kolek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vı́tězslav Kolek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vı́tězslav Kolek more than expected).
Fields of papers citing papers by Vı́tězslav Kolek
This network shows the impact of papers produced by Vı́tězslav Kolek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vı́tězslav Kolek. The network helps show where Vı́tězslav Kolek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vı́tězslav Kolek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 2 | |
| 2 | 2019 | 1 | |
| 3 | 2019 | 1 | |
| 4 | 2017 | 0 | |
| 5 | 2016 | 10 | |
| 6 | 2016 | 1 | |
| 7 | 2015 | 22 | |
| 8 | 2014 | 1 | |
| 9 | 2014 | 6 | |
| 10 | 2014 | 2 | |
| 11 | 2014 | 14 | |
| 12 | 2014 | 7 | |
| 13 | 2014 | 3 | |
| 14 | 2013 | 1 | |
| 15 | 2012 | 2 | |
| 16 | Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized Trial | 2003 | 41 |
| 17 | 2003 | 26 | |
| 18 | 2003 | 16 | |
| 19 | 2002 | 100 | |
| 20 | 2000 | 88 |
About Vı́tězslav Kolek
Vı́tězslav Kolek is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology, having authored 87 papers that have together received 1.4k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Sarcoidosis and Beryllium Toxicity Research (21 papers), Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (16 papers), Lung Cancer Diagnosis and Treatment (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Pneumonia and Respiratory Infections (6 papers) and Obstructive Sleep Apnea Research (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (746 citations), Oncology (413 citations) and Physiology (356 citations). Vı́tězslav Kolek has collaborated with scholars based in Czechia, United Kingdom and Israel. Frequent co-authors include Martin Petřek, Zdeňka Navrátilová, Roland M. du Bois, Jir̆ı́ Drábek, Kenneth I. Welsh, Eva Kriegová, Jozef Škarda, František Mrázek, Monika Žůrková and Beata Hutyrová. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.